img

Global Adenosine Deaminase Deficiency Treatment Market Research Report 2024


Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Adenosine Deaminase Deficiency Treatment Market Research Report 2024

Adenosine deaminase deficiency is an autosomal recessive metabolic disorder that causes immunodeficiency. It occurs in fewer than one in 100,000 live births worldwide.
According to Mr Accuracy reports new survey, global Adenosine Deaminase Deficiency Treatment market is projected to reach US$ 174.1 million in 2029, increasing from US$ 131.5 million in 2022, with the CAGR of 4.2% during the period of 2024 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Adenosine Deaminase Deficiency Treatment market research.
The market driver for Adenosine Deaminase Deficiency (ADA) therapeutic products is the critical need to address this rare and life-threatening genetic disorder. ADA-SCID severely compromises the immune system, making effective treatment essential. Gene therapies and enzyme replacement therapies have shown promise in restoring immune function, driving market growth. However, challenges include limited patient population, high treatment costs, and the need for early and accurate diagnosis. Additionally, access to these specialized therapies and regulatory hurdles pose challenges. Despite challenges, the ADA therapeutic market presents opportunities for further research and development, offering hope for improved outcomes for patients with this devastating condition.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Adenosine Deaminase Deficiency Treatment market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.



By Company


Leadiant Biosciences
Chiesi
Segment by Type
Adagen
Revcovi

Segment by Application


Hospital
Pharmacy
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The Adenosine Deaminase Deficiency Treatment report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Global market size, regional market size. Market Opportunities and Challenges
Chapter 3Companies’ Competition Patterns
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6 to 10Country Level Value Analysis
Chapter 11Companies' Outline
Chapter 12Market Conclusions
Chapter 13Research Methodology and Data Source

Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Adenosine Deaminase Deficiency Treatment Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Adagen
1.2.3 Revcovi
1.3 Market by Application
1.3.1 Global Adenosine Deaminase Deficiency Treatment Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Hospital
1.3.3 Pharmacy
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Adenosine Deaminase Deficiency Treatment Market Perspective (2018-2029)
2.2 Adenosine Deaminase Deficiency Treatment Growth Trends by Region
2.2.1 Global Adenosine Deaminase Deficiency Treatment Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Adenosine Deaminase Deficiency Treatment Historic Market Size by Region (2018-2024)
2.2.3 Adenosine Deaminase Deficiency Treatment Forecasted Market Size by Region (2024-2029)
2.3 Adenosine Deaminase Deficiency Treatment Market Dynamics
2.3.1 Adenosine Deaminase Deficiency Treatment Industry Trends
2.3.2 Adenosine Deaminase Deficiency Treatment Market Drivers
2.3.3 Adenosine Deaminase Deficiency Treatment Market Challenges
2.3.4 Adenosine Deaminase Deficiency Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Adenosine Deaminase Deficiency Treatment Players by Revenue
3.1.1 Global Top Adenosine Deaminase Deficiency Treatment Players by Revenue (2018-2024)
3.1.2 Global Adenosine Deaminase Deficiency Treatment Revenue Market Share by Players (2018-2024)
3.2 Global Adenosine Deaminase Deficiency Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Adenosine Deaminase Deficiency Treatment Revenue
3.4 Global Adenosine Deaminase Deficiency Treatment Market Concentration Ratio
3.4.1 Global Adenosine Deaminase Deficiency Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Adenosine Deaminase Deficiency Treatment Revenue in 2022
3.5 Adenosine Deaminase Deficiency Treatment Key Players Head office and Area Served
3.6 Key Players Adenosine Deaminase Deficiency Treatment Product Solution and Service
3.7 Date of Enter into Adenosine Deaminase Deficiency Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Adenosine Deaminase Deficiency Treatment Breakdown Data by Type
4.1 Global Adenosine Deaminase Deficiency Treatment Historic Market Size by Type (2018-2024)
4.2 Global Adenosine Deaminase Deficiency Treatment Forecasted Market Size by Type (2024-2029)
5 Adenosine Deaminase Deficiency Treatment Breakdown Data by Application
5.1 Global Adenosine Deaminase Deficiency Treatment Historic Market Size by Application (2018-2024)
5.2 Global Adenosine Deaminase Deficiency Treatment Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Adenosine Deaminase Deficiency Treatment Market Size (2018-2029)
6.2 North America Adenosine Deaminase Deficiency Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Adenosine Deaminase Deficiency Treatment Market Size by Country (2018-2024)
6.4 North America Adenosine Deaminase Deficiency Treatment Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Adenosine Deaminase Deficiency Treatment Market Size (2018-2029)
7.2 Europe Adenosine Deaminase Deficiency Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Adenosine Deaminase Deficiency Treatment Market Size by Country (2018-2024)
7.4 Europe Adenosine Deaminase Deficiency Treatment Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Adenosine Deaminase Deficiency Treatment Market Size (2018-2029)
8.2 Asia-Pacific Adenosine Deaminase Deficiency Treatment Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Adenosine Deaminase Deficiency Treatment Market Size by Region (2018-2024)
8.4 Asia-Pacific Adenosine Deaminase Deficiency Treatment Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Adenosine Deaminase Deficiency Treatment Market Size (2018-2029)
9.2 Latin America Adenosine Deaminase Deficiency Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Adenosine Deaminase Deficiency Treatment Market Size by Country (2018-2024)
9.4 Latin America Adenosine Deaminase Deficiency Treatment Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Adenosine Deaminase Deficiency Treatment Market Size (2018-2029)
10.2 Middle East & Africa Adenosine Deaminase Deficiency Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Adenosine Deaminase Deficiency Treatment Market Size by Country (2018-2024)
10.4 Middle East & Africa Adenosine Deaminase Deficiency Treatment Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Leadiant Biosciences
11.1.1 Leadiant Biosciences Company Detail
11.1.2 Leadiant Biosciences Business Overview
11.1.3 Leadiant Biosciences Adenosine Deaminase Deficiency Treatment Introduction
11.1.4 Leadiant Biosciences Revenue in Adenosine Deaminase Deficiency Treatment Business (2018-2024)
11.1.5 Leadiant Biosciences Recent Development
11.2 Chiesi
11.2.1 Chiesi Company Detail
11.2.2 Chiesi Business Overview
11.2.3 Chiesi Adenosine Deaminase Deficiency Treatment Introduction
11.2.4 Chiesi Revenue in Adenosine Deaminase Deficiency Treatment Business (2018-2024)
11.2.5 Chiesi Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Adenosine Deaminase Deficiency Treatment Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029
Table 2. Key Players of Adagen
Table 3. Key Players of Revcovi
Table 4. Global Adenosine Deaminase Deficiency Treatment Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2029
Table 5. Global Adenosine Deaminase Deficiency Treatment Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 6. Global Adenosine Deaminase Deficiency Treatment Market Size by Region (2018-2024) & (US$ Million)
Table 7. Global Adenosine Deaminase Deficiency Treatment Market Share by Region (2018-2024)
Table 8. Global Adenosine Deaminase Deficiency Treatment Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 9. Global Adenosine Deaminase Deficiency Treatment Market Share by Region (2024-2029)
Table 10. Adenosine Deaminase Deficiency Treatment Market Trends
Table 11. Adenosine Deaminase Deficiency Treatment Market Drivers
Table 12. Adenosine Deaminase Deficiency Treatment Market Challenges
Table 13. Adenosine Deaminase Deficiency Treatment Market Restraints
Table 14. Global Adenosine Deaminase Deficiency Treatment Revenue by Players (2018-2024) & (US$ Million)
Table 15. Global Adenosine Deaminase Deficiency Treatment Market Share by Players (2018-2024)
Table 16. Global Top Adenosine Deaminase Deficiency Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Adenosine Deaminase Deficiency Treatment as of 2022)
Table 17. Ranking of Global Top Adenosine Deaminase Deficiency Treatment Companies by Revenue (US$ Million) in 2022
Table 18. Global 5 Largest Players Market Share by Adenosine Deaminase Deficiency Treatment Revenue (CR5 and HHI) & (2018-2024)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Adenosine Deaminase Deficiency Treatment Product Solution and Service
Table 21. Date of Enter into Adenosine Deaminase Deficiency Treatment Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Adenosine Deaminase Deficiency Treatment Market Size by Type (2018-2024) & (US$ Million)
Table 24. Global Adenosine Deaminase Deficiency Treatment Revenue Market Share by Type (2018-2024)
Table 25. Global Adenosine Deaminase Deficiency Treatment Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 26. Global Adenosine Deaminase Deficiency Treatment Revenue Market Share by Type (2024-2029)
Table 27. Global Adenosine Deaminase Deficiency Treatment Market Size by Application (2018-2024) & (US$ Million)
Table 28. Global Adenosine Deaminase Deficiency Treatment Revenue Market Share by Application (2018-2024)
Table 29. Global Adenosine Deaminase Deficiency Treatment Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 30. Global Adenosine Deaminase Deficiency Treatment Revenue Market Share by Application (2024-2029)
Table 31. North America Adenosine Deaminase Deficiency Treatment Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 32. North America Adenosine Deaminase Deficiency Treatment Market Size by Country (2018-2024) & (US$ Million)
Table 33. North America Adenosine Deaminase Deficiency Treatment Market Size by Country (2024-2029) & (US$ Million)
Table 34. Europe Adenosine Deaminase Deficiency Treatment Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 35. Europe Adenosine Deaminase Deficiency Treatment Market Size by Country (2018-2024) & (US$ Million)
Table 36. Europe Adenosine Deaminase Deficiency Treatment Market Size by Country (2024-2029) & (US$ Million)
Table 37. Asia-Pacific Adenosine Deaminase Deficiency Treatment Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2029
Table 38. Asia-Pacific Adenosine Deaminase Deficiency Treatment Market Size by Region (2018-2024) & (US$ Million)
Table 39. Asia-Pacific Adenosine Deaminase Deficiency Treatment Market Size by Region (2024-2029) & (US$ Million)
Table 40. Latin America Adenosine Deaminase Deficiency Treatment Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 41. Latin America Adenosine Deaminase Deficiency Treatment Market Size by Country (2018-2024) & (US$ Million)
Table 42. Latin America Adenosine Deaminase Deficiency Treatment Market Size by Country (2024-2029) & (US$ Million)
Table 43. Middle East & Africa Adenosine Deaminase Deficiency Treatment Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 44. Middle East & Africa Adenosine Deaminase Deficiency Treatment Market Size by Country (2018-2024) & (US$ Million)
Table 45. Middle East & Africa Adenosine Deaminase Deficiency Treatment Market Size by Country (2024-2029) & (US$ Million)
Table 46. Leadiant Biosciences Company Detail
Table 47. Leadiant Biosciences Business Overview
Table 48. Leadiant Biosciences Adenosine Deaminase Deficiency Treatment Product
Table 49. Leadiant Biosciences Revenue in Adenosine Deaminase Deficiency Treatment Business (2018-2024) & (US$ Million)
Table 50. Leadiant Biosciences Recent Development
Table 51. Chiesi Company Detail
Table 52. Chiesi Business Overview
Table 53. Chiesi Adenosine Deaminase Deficiency Treatment Product
Table 54. Chiesi Revenue in Adenosine Deaminase Deficiency Treatment Business (2018-2024) & (US$ Million)
Table 55. Chiesi Recent Development
Table 56. Research Programs/Design for This Report
Table 57. Key Data Information from Secondary Sources
Table 58. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Adenosine Deaminase Deficiency Treatment Market Size Comparison by Type (2024-2034) & (US$ Million)
Figure 2. Global Adenosine Deaminase Deficiency Treatment Market Share by Type: 2022 VS 2029
Figure 3. Adagen Features
Figure 4. Revcovi Features
Figure 5. Global Adenosine Deaminase Deficiency Treatment Market Size Comparison by Application (2024-2034) & (US$ Million)
Figure 6. Global Adenosine Deaminase Deficiency Treatment Market Share by Application: 2022 VS 2029
Figure 7. Hospital Case Studies
Figure 8. Pharmacy Case Studies
Figure 9. Adenosine Deaminase Deficiency Treatment Report Years Considered
Figure 10. Global Adenosine Deaminase Deficiency Treatment Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 11. Global Adenosine Deaminase Deficiency Treatment Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 12. Global Adenosine Deaminase Deficiency Treatment Market Share by Region: 2022 VS 2029
Figure 13. Global Adenosine Deaminase Deficiency Treatment Market Share by Players in 2022
Figure 14. Global Top Adenosine Deaminase Deficiency Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Adenosine Deaminase Deficiency Treatment as of 2022)
Figure 15. The Top 10 and 5 Players Market Share by Adenosine Deaminase Deficiency Treatment Revenue in 2022
Figure 16. North America Adenosine Deaminase Deficiency Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 17. North America Adenosine Deaminase Deficiency Treatment Market Share by Country (2018-2029)
Figure 18. United States Adenosine Deaminase Deficiency Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 19. Canada Adenosine Deaminase Deficiency Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 20. Europe Adenosine Deaminase Deficiency Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 21. Europe Adenosine Deaminase Deficiency Treatment Market Share by Country (2018-2029)
Figure 22. Germany Adenosine Deaminase Deficiency Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 23. France Adenosine Deaminase Deficiency Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 24. U.K. Adenosine Deaminase Deficiency Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 25. Italy Adenosine Deaminase Deficiency Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 26. Russia Adenosine Deaminase Deficiency Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 27. Nordic Countries Adenosine Deaminase Deficiency Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 28. Asia-Pacific Adenosine Deaminase Deficiency Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 29. Asia-Pacific Adenosine Deaminase Deficiency Treatment Market Share by Region (2018-2029)
Figure 30. China Adenosine Deaminase Deficiency Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 31. Japan Adenosine Deaminase Deficiency Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 32. South Korea Adenosine Deaminase Deficiency Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 33. Southeast Asia Adenosine Deaminase Deficiency Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 34. India Adenosine Deaminase Deficiency Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 35. Australia Adenosine Deaminase Deficiency Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 36. Latin America Adenosine Deaminase Deficiency Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 37. Latin America Adenosine Deaminase Deficiency Treatment Market Share by Country (2018-2029)
Figure 38. Mexico Adenosine Deaminase Deficiency Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 39. Brazil Adenosine Deaminase Deficiency Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 40. Middle East & Africa Adenosine Deaminase Deficiency Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 41. Middle East & Africa Adenosine Deaminase Deficiency Treatment Market Share by Country (2018-2029)
Figure 42. Turkey Adenosine Deaminase Deficiency Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 43. Saudi Arabia Adenosine Deaminase Deficiency Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 44. Leadiant Biosciences Revenue Growth Rate in Adenosine Deaminase Deficiency Treatment Business (2018-2024)
Figure 45. Chiesi Revenue Growth Rate in Adenosine Deaminase Deficiency Treatment Business (2018-2024)
Figure 46. Bottom-up and Top-down Approaches for This Report
Figure 47. Data Triangulation
Figure 48. Key Executives Interviewed